Showing results (291-300 of 311) with videos related to

Sort By:
Pageof 32
Nature Communications|September 11, 2023
Contribution of common and rare variants to Asian neovascular age-related macular degeneration subtypesQiao Fan, Hengtong Li, Xiaomeng Wang, et al.
International Journal of Epidemiology|October 13, 2017
HDL-cholesterol levels and risk of age-related macular degeneration: a multiethnic genetic study using Mendelian randomizationQiao Fan, Joseph C Maranville, Lars Fritsche, et al.
Ophthalmology and Therapy|December 13, 2024
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular DegenerationAnat Loewenstein, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|February 2, 2023
Polypoidal Choroidal Vasculopathy: Updates on Risk Factors, Diagnosis, and TreatmentsPaisan Ruamviboonsuk, Timothy Y Y Lai, Shih-Jen Chen, et al.
Ophthalmology and Therapy|March 28, 2026
Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET StudyKelvin Yi Chong Teo, Young Hee Yoon, Shigeru Honda, et al.
Acta Ophthalmologica|April 7, 2022
Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic careMarc J Sirks, Elon H C van Dijk, Noa Rosenberg, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 4, 2021
Efficacy and Safety of Intravitreal Aflibercept Treat and Extend for Polypoidal Choroidal Vasculopathy in the ATLANTIC Study: A Randomized Clinical TrialRufino Silva, Luis Arias, Sandrina Nunes, et al.
Progress in Retinal and Eye Research|November 13, 2025
Polypoidal choroidal vasculopathy: In-depth insights and promising future directionsZuyi Yang, Wenfei Zhang, Xingwang Gu, et al.
Pageof 32